Literature DB >> 8220883

Eicosanoid-dependence of responses of pre- but not postglomerular vessels to noradrenaline in rat isolated kidneys.

B L Zhang1, J Sassard.   

Abstract

1. We investigated the role of nitric oxide (NO) and of vasoactive eicosanoids in the control of renal vascular resistance (RVR) and glomerular filtration rate (GFR) and of their responses to noradrenaline (NA). This study was conducted in single-pass perfused, isolated kidney preparations of the rat. 2. NA (63, 110 and 160 nM) dose-dependently increased RVR and to a lesser degree GFR. 3. In baseline conditions, N omega-nitro-L-arginine methylester (L-NAME, 100 microM) increased GFR more than RVR, thus demonstrating a basal release of NO which predominates in postglomerular vessels. 4. In kidneys stimulated with NA, L-NAME potentiated the increases in RVR but not in GFR. Indomethacin (1.5, 150 nM and 15 microM) did not alter GFR but markedly and dose-dependently reduced the NA-induced increase in RVR. Similar results were obtained with GR 32191B (10 and 100 microM), a prostaglandin H2/thromboxane A2 (PGH2/TxA2) receptor antagonist. 5. Indomethacin (15 microM) suppressed the enhancing effects of L-NAME on RVR responses to NA but did not affect those on GFR. 6. It is concluded that the mechanisms of the response to NA differ among pre- and postglomerular vessels. In preglomerular vessels the vasoconstrictor action and the NO release depend upon the activation of PGH2/TxA2 receptors, while both are eicosanoid-independent in the postglomerular vessels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220883      PMCID: PMC2175988          DOI: 10.1111/j.1476-5381.1993.tb13798.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Endothelial regulation of wall shear stress and blood flow in skeletal muscle microcirculation.

Authors:  A Koller; G Kaley
Journal:  Am J Physiol       Date:  1991-03

2.  Endogenous vasoconstrictor prostanoids: role in serotonin and vasopressin-induced coronary vasoconstriction.

Authors:  S L Lee; S Levitsky; H Feinberg
Journal:  J Pharmacol Exp Ther       Date:  1991-07-01       Impact factor: 4.030

Review 3.  Long-term control of arterial blood pressure.

Authors:  A W Cowley
Journal:  Physiol Rev       Date:  1992-01       Impact factor: 37.312

4.  Endothelium-derived relaxing factor influences renal vascular resistance.

Authors:  J Radermacher; U Förstermann; J C Frölich
Journal:  Am J Physiol       Date:  1990-07

5.  Effects of amino acid infusion on renal hemodynamics. Role of endothelium-derived relaxing factor.

Authors:  J P Tolins; L Raij
Journal:  Hypertension       Date:  1991-06       Impact factor: 10.190

6.  Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed.

Authors:  D Lamontagne; U Pohl; R Busse
Journal:  Circ Res       Date:  1992-01       Impact factor: 17.367

7.  Suppression of blood flow autoregulation plateau during nitric oxide blockade in canine kidney.

Authors:  D S Majid; L G Navar
Journal:  Am J Physiol       Date:  1992-01

8.  Pharmacological characterization of renal vascular dopamine receptors.

Authors:  M Schmidt; J L Imbs
Journal:  J Cardiovasc Pharmacol       Date:  1980 Sep-Oct       Impact factor: 3.105

9.  Role of endothelium in endothelin-evoked contractions in the rat aorta.

Authors:  S Taddei; P M Vanhoutte
Journal:  Hypertension       Date:  1993-01       Impact factor: 10.190

10.  Adrenergic stimulation of renal prostanoids in the Lyon hypertensive rat.

Authors:  K L Liu; A H Aissa; M C Laréal; D Benzoni; M Vincent; J Sassard
Journal:  Hypertension       Date:  1991-03       Impact factor: 10.190

View more
  3 in total

1.  Renal response to anaphylaxis in anesthetized rats and isolated perfused rat kidneys: roles of nitric oxide.

Authors:  Kiyotaka Mukai; Yuhichi Kuda; Toshishige Shibamoto; Mamoru Tanida; Yasutaka Kurata; Hitoshi Yokoyama
Journal:  J Physiol Sci       Date:  2017-12-05       Impact factor: 2.781

2.  Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat.

Authors:  A Ziyyat; B L Zhang; D Benzoni
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

3.  Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.

Authors:  F Fabi; R Calabrese; T Stati; P del Basso
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.